Skip to main content
. 2021 Sep 4;2021:6673967. doi: 10.1155/2021/6673967

Figure 9.

Figure 9

Tilianin provided neuroprotection to OGD-injured hNCs. (a) Increased viability of OGD-injured hNCs treated with tilianin as evaluated by CCL assay (n = 6). (b) Decreased percentage of TUNEL-positive cells in OGD-injured hNCs treated by tilianin. (c) Representative images of TUNEL staining. Bar: 100 μm. (d) Decreased caspase-3 activity in OGD-injured hNCs treated with tilianin. Results represent means ± SD. ###P < 0.001 vs. control group; P < 0.05, ∗∗P < 0.01 vs. OGD group.